[2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS].
By Paulus Kirchhof, S. Benussi, D. Kotecha, A. Ahlsson, D. Atar, B. Casadei, M. Castellà, H. Diener, H. Heidbuchel, J. Hendriks and 7 more. Kardiologia polska, 2016
1,744 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Economics and Econometrics
View Paper: https://www.semanticscholar.org/paper/b8a8ae9a5acaff86392f38534a4ad36b1832fef8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Jeroen J. Bax
- A. Goette
- Helmut Baumgartner
- J. Halperin
- James K. Min
- Volkmar Falk
- Jose Luis Zamorano
- P. Lancellotti
Citations in the corpus
- 2020 ESC Guidelines for the management of adult congenital heart disease (2021, neutral): “If IART/AF is tolerated and lasting >_48 h, cardiac thrombus needs to be ruled out (TOE) and/or appropriate anticoagulation (>3 weeks) and pharmacological rate control needs to be initiated before cardioversion using a beta blocker or calcium channel blocker (in patients with normal systemic ventric”
- [2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017, background): “The use of prasugrel or ticagrelor as part of triple therapy should be avoided.(37) During triple antithrombotic therapy, close monitoring of INR is advised and INR should be kept in the low target range.”
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. (2018, methodology): “Based on these premises, the European Heart Rhythm Association (EHRA) set out to coordinate a unified way of informing physicians on the use of NOACs.”
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016, neutral): “For details, the reader should refer to the 2016 ESC guidelines on AF.(316)”
- Deep learning for cardiovascular medicine: a practical primer. (2019, background): “strip, based on evidence on cost effectiveness.(81) Therefore, integrating DL into wearable technology for intermittent screening for silent AF may be cost effective by preventing sequelae such as stroke.”
- The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health (2020, background): “Atrial fibrillation is characterized on an EKG by the absence of P waves with irregular R-R intervals due to irregular beating of the atria leading to irregular conduction of impulses to the ventricles (64).”